FDA Approved: PREVACID — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for PREVACID (lansoprazole) submitted by Takeda Pharmaceuticals America, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Nsaid-induced Gastroduodenal Ulcer

Drugs mentioned

• PREVACID (LANSOPRAZOLE)

Snippet

SUPPL AP for PREVACID (LANSOPRAZOLE)